Yeast double-stranded RNA virus L-A deliberately synthesizes RNA transcripts with 5′-Diphosphate by Fujimura, Tsutomu & Esteban, Rosa
     5’ diphosphate terminus of L-A transcript 
	   1	  
YEAST DOUBLE-STRANDED RNA VIRUS L-A DELIBERATELY SYNTHESIZES 
RNA TRANSCRIPTS WITH 5’ DIPHOSPHATE* 
Tsutomu Fujimura and Rosa Esteban 
From the Instituto de Microbiología Bioquímica/Departamento de Microbiología y Genética. 
Consejo Superior de Investigaciones Científicas/Universidad de Salamanca. Salamanca. Spain 
Running title: 5’ diphosphate terminus of L-A transcript 
Address correspondence to: Tsutomu Fujimura. Instituto de Microbiología Bioquímica CSIC /Universidad 
de Salamanca, Avda. del Campo Charro s/n Salamanca 37007, Spain, Tel. 34-923-120673; Fax. 34-923-
224876; E-mail: tfujimura@usal.es 
 
L-A is a persistent double-stranded 
RNA virus commonly found in the yeast 
Saccharomyces cerevisiae. Isolated L-A virus 
synthesizes positive strand transcripts in vitro. 
We found that the 5’ termini of the transcripts 
are diphosphorylated.  The 5’ terminal 
nucleotide is G and GDP was the best substrate 
among those examined to prime the reaction. 
When GTP was used, the triphosphate of GTP 
incorporated into the 5’ end was converted to 
diphosphate. This activity was not dependent on 
host CTL1 RNA triphosphatase. The 5’ end of 
GMP-primed transcript was also converted to 
diphosphate, the β  phosphate of which was 
derived from the γ  phosphate of ATP present in 
the polymerization reaction. These results 
demonstrate that L-A virus commands 
elaborate enzymatic systems to ensure its 
transcript to be 5’ diphosphorylated.  
Transcripts of M1, a satellite RNA of L-A virus, 
also had diphosphate at the 5’ termini. Because 
viral transcripts are released from the virion 
into the cytoplasm to be translated and to be 
encapsidated into a new viral particle, a stage 
most vulnerable to degradation in the virus 
replication cycle, our results suggest that the 5’ 
diphosphate status is important for transcript 
stability. Consistent with this, L-A transcripts 
made in vitro are resistant to the affinity-
purified Ski1p 5’ exonuclease. We also discuss 
the implication of these findings on translation 
of viral RNA. Because the viral transcript has 
no conventional 5’ cap structure, this work may 
shed light on the metabolism of non-self RNA in 
yeast.  
 
 The 5’ cap (m7GpppXp) and 3’ poly(A) 
tail structures are the hallmark of eukaryotic 
mRNAs and have important biological functions in 
promoting stability in the nucleus, transport to the 
cytoplasm, and translation and stability in the 
cytoplasm. Therefore, many viruses furnish their 
transcripts with the 5’ cap structure utilizing their 
own or cellular enzymes, or even by snatching the 
structure from cellular mRNAs (1 - 3). Transcripts 
made by T7 RNA polymerase are recognized as 
foreign and induce innate immune responses in 
animal cells. Recent studies suggest that the 5’ 
triphosphate of the transcripts as well as secondary 
structure, are involved in these responses (4, 5). 
Therefore, the 5’ end of RNA bears important 
information concerning on self or non-self for the 
host cells. 
L-A is a persistent double–stranded RNA 
(dsRNA)1 virus commonly found in the laboratory 
strains of the yeast Saccharomyces cerevisiae (6). 
The virus has no extracellular transmission 
pathway. The viral genome is 4.6 kb long and only 
one strand (the positive strand) encodes proteins: 
The major 76 KDa coat protein Gag and a minor 
170 KDa Gag-Pol (7, 8). The minor protein is 
made from the two overlapping genes by a -1 
ribosomal frameshifting mechanism (9).  The Pol 
domain of the fusion protein has the consensus 
motifs for RNA-dependent RNA polymerases. The 
RNA genome is packed inside of a 39 nm 
icosahedral shell consisting of 60 Gag 
heterodimers (10, 11).  One molecule or two of 
Gag is replaced by Gag-Pol because the fusion 
protein is essential for RNA encapsidation and 
replication.  L-A virions have transcriptase activity 
to synthesize full-length positive strands from the 
dsRNA genome in a conservative way (12). The 
transcripts are extruded from the virions and serve 
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as templates for translation and also as substrates 
for encapsidation to form new virions. Once 
encapsidated, the positive strand is converted to 
dsRNA by the replicase activity associated with 
the virion. 
M1, a satellite RNA of L-A virus, requires 
L-A encoded proteins to encapsidate and replicate 
its RNA genome. M1 dsRNA (1.6 to 1.8 kb) 
encodes a secreted protein toxin (killer toxin) that 
kills M1-free, toxin–sensitive strains (13). Using 
this killer phenotype as a marker various host 
chromosomal genes have been identified which 
affect replication and maintenance of M1 and L-A. 
Mutations in SKI genes (SKI1, 2, 3, 4, 6, 7, and 8) 
cause an elevated copy number of L-A and, in the 
presence of M1, exhibit a “superkiller” phenotype 
(14, 15). 
 Degradation of mRNA in eukaryotes 
usually begins with shortening of the poly(A) tail 
at the 3’ end followed by decapping at the 5’ end 
by the Dcp1p-Dcp2p decapping enzyme. 
Decapping generates the mRNA body with 5’ 
monophosphate, which is then degraded by the 
SKI1/XRN1 5’ exonuclease (16, 17). Alternatively, 
the deadenylated RNA is digested by a 
multiprotein complex with 3’ exonuclease activity 
called the exosome.   Products of SKI2, 3, 4, 6, 7, 
and 8 are auxiliary or core components of the 
cytoplasmic exosome (18, 19). These gene 
products are also known to prevent translation 
from RNA without 3’ poly(A) tail (20, 21).    
Previously we observed a strong antiviral 
activity of SKI1 against L-A virus (22). Deletion of 
SKI1 elevated the copy number of L-A 5- to 10-
fold and overexpression of the gene cured L-A 
virus from cells at a high frequency. In the 
replication cycle of L-A virus only positive strand 
transcripts are released from virions into the 
cytoplasm. We therefore reasoned that the L-A 
transcript at this stage is vulnerable to the SKI1 5’ 
exonuclease. The nuclease requires 5’ 
monophosphorylated RNA as substrate, while the 
5’ end of L-A transcript has not been well 
established. It was reported about three decades 
ago that the 5’ terminus was triphosphorylated (23) 
or diphosphorylated (24). Here we establish that L-
A has diphosphate at the 5’ end. More significantly 
we demonstrate that the phosphate group of GTP 
or GMP, when the nucleotide was incorporated at 
the 5’ end of the transcript, was converted to 
diphosphate. The virus, thus, clearly avoids 5’ tri- 
or monophosphorylated transcripts. Our work may 
shed light on the metabolism of non-self RNA in 
yeast, especially on the role of phosphate groups at 
the RNA 5’ end. 
 
EXPERIMENTAL PROCEDURES 
 
Strains and Media - Strain 2404 (a kar1-1 
his4, L-A-HN, L-BC, M-o) was used to obtain 
wild type L-A virions. 2927 (a ura3 trp1 his3 ski2-
2, L-A-o L-BC-o) was used to prepare a L-A-free 
cell extract. A	   ctl1Δ strain was obtained from a 
haploid deletion series (BY4741 (a ura3Δ0, 
leu2Δ0 his3Δ1, met15Δ0 20S RNA-o, 23S RNA-o, 
L-A) background) of the EUROFAN collection. L-
A-free killer strain (a, trp1, ura3, leu2, his3, 
pep4::HIS3, nuc1::LEU2, L-A-o, M1, L-BC, 
pAB2) was obtained from Reed B. Wickner (25). 
L-A proteins expressed from plasmid pAB2 
support replication of M1 in this strain. Cells were 
grown in rich YPAD medium (1% yeast extract, 
2% peptone, 0.04% adenine sulphate, and 2% 
glucose) or synthetic medium deprived of uracil 
(H-ura) or trp (H-trp) (26). L-A and M1 virions 
were isolated and purified through CsCl gradient 
centrifugation as described in (27). 
 
 Transcription Reaction- The standard 
transcription reaction mixture contained 50 mM 
Tris HCl pH 7.5, 5 mM MgCl2, 0.1 mM EDTA, 20 
mM NaCl, 5 mM KCl, 1 mM DTT, 2.5 mg of 
bentonite per ml, 0.5 mM each ATP, CTP, GTP 
and UTP. When a radioactive nucleotide was used, 
the concentration was reduced to 20 µM. The 
reaction was started by the addition of purified L-
A or M1 virions and incubated at 30 ºC. The RNA 
products were extracted with phenol, phenol-
chloroform and precipitated with ethanol. Then the 
RNA was separated in either a 1.3% agarose or a 
15% acryalamide gel, depending on the size of the 
products. Radioactive products were visualized by 
autoradiography. Non-radioactive RNA was 
detected by ethidium bromide staining or by 
Northern hybridization (28) using a 32P-labeled 
specific probe. 
  
Ski1p-TAP Purification- Tandem affinity 
purification (TAP)-tagged Ski1p was expressed in 
strain 2928-4 (a ura3 trp1 his3, L-A-o, L-BC) 
harboring plasmid pRE1004 by growing the cells 
in H-ura medium in which glucose was substituted 
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with 2% galactose. pRE1004 is a derivative of 
pEMBLyex4 (29) with a 5.3 kb BamHI fragment 
that contains the entire SKI1 coding sequence 
directly fused to TAP at the carboxyl terminus. 
The expression of the protein is under the control 
of the GAL1-CYC hybrid promoter. Ski1p-TAP 
was purified in a single-step purification with 
calmodulin affinity resin (Stratagene) (30, 31). 
Briefly, a cell lysate was prepared by breaking the 
cells by a FastPrep (BIO 101 SAVANT) in a 
buffer containing 20 mM Tris HCl pH 8.0, 100 
mM NaCl, 1 mM phenylmethylsulfonyl fluoride 
and 1x protease inhibitor (GE Healthcare) and 
clarified by centrifugation at 50,000 rpm for 1 h 
with a TLA100.2 rotor. The supernatant was 
dialyzed against IPP 150 calmodulin binding 
buffer (10 mM β-mercaptoethanol, 10 mM Tris 
HCl pH 8.0, 150 mM NaCl, 1 mM magnesium 
acetate, 1 mM imidazole, 2 mM CaCl2, 0.1% 
NP40) for 1 h and then incubated for 1 h with 200 
µl calmodulin affinity resin pre-equilibrated with 
IPP 150 calmodulin binding buffer. The mixture 
was transferred to a column and then the column 
was washed with 40 ml IPP 150 calmodulin 
binding buffer. The bound protein was eluted 
stepwise with IPP 150 calmodulin elution buffer 
(10 mM β-mercaptoethanol, 10 mM Tris HCl pH 
8.0, 150 mM NaCl, 1 mM magnesium acetate, 1 
mM imidazole, 2 mM EGTA, 0.1% NP40). The 
eluted protein was analyzed by SDS 
polyacrylamide gel electrophoresis followed by 
silver staining. Fr. 3 (lane 4 in Fig. 6A) contained 
the highest concentration of Ski1p-TAP (0.09 
mg/ml) among elutes, estimated by Bradford 
method (32) using BSA as standard. 
 
T7 Transcripts with Different 5’ Ends- T7 
transcripts with different 5’ ends were made by 
run-off transcription with T7 RNA polymerase as 
described in (33). 5’ monophosphorylated and 
capped RNAs were synthesized by the addition of 
an excess amount of GMP and m7GpppG cap 
analogue, respectively, over GTP. We used PvuII-
digested pTF60 as template. pTF60 contains only 
two extra Gs between the T7 promoter and the 
entire X cDNA sequence (27). X  (530 bp) is a 
mutant of L-A with a large internal deletion (34). 
 
Enzyme Digestions- Terminator 5’ 
exonuclease or Ski1p-TAP digestion was carried 
out in a buffer containing 50 mM Tris HCl pH 8.0, 
2 mM MgCl2, 0.1 M NaCl and 0.5 units 
Terminator or 30 ng of Ski1p-TAP. RNA 5’ 
polyphosphatase: 50 mM HEPES KOH pH 7.5, 0.1 
M NaCl, 1 mM EDTA, 0.1% β-mercaptoethanol, 
0.01% Triton X-100 and 10 units of the enzyme. SI 
nuclease: 30 mM Na acetate pH 4.5, 60 mM NaCl, 
1 mM ZnCl2, and 20 units of S1. Bacterial alkaline 
phosphatase (BAP): 10 mM Tris HCl pH 8.0 and 
30 units of BAP. Tobacco acid pyrophosphatase: 
50 mM Na acetate pH 6.0, 1 mM EDTA, 0.1% β-
mercaptoethanol, 0.01% Triton X-100 and 5 units 
of the enzyme. All the reactions were carried out at 
37 ºC for 30 min except that Terminator 5’ 
exonuclease and Ski1p-TAP were incubated at 30 
ºC. 
   
Miscellaneous- Radioactive nucleotides 
were obtained from Perkin Elmer. Terminator 5’ 
exonuclease and RNA 5’ polyphosphatase are 
from Epicentre. S1 nuclease from Promega. BAP 
from Invitrogen. Tobacco acid pyrophosphatase, γ-
S-GTP and β-S-GDP from Sigma-Aldrich. 
m7GpppG cap analogue from Ambion. Malachite 
Green Reagent from Biomol. 
   
RESULTS 
 
L-A Transcript has Diphosphate at the 5’ 
End- Purified L-A virions have RNA polymerase 
activity and synthesize full-length positive-strand 
transcripts using the dsRNA genome as template. 
The RNA products were resistant to Terminator 5’ 
exonuclease (Fig. 1A, lane 2). The enzyme 
processively hydrolyzes single-stranded RNA with 
5’ monophosphate in a 5’-3’ direction. 
Pretreatment with RNA 5’ polyphosphatase, 
however, converted the RNA to full sensitivity to 
the 5’ exonuclease (Fig. 1A, lane 4). The 
polyphosphatase removes the γ and β phosphates 
from 5’ tri- or diphosphorylated RNA but has no 
activity on RNA with a 5’ cap. These results 
indicate that the L-A transcripts have no 5’ cap 
structure and suggest that the transcripts are tri- or 
diphosphorylated at their 5´ends.  
 The 5’ region of L-A positive strand starts 
with a G followed by an AU-rich sequence (Fig. 
1B, upper diagram). The first U and C appear at 
positions 7 and 17, respectively.  When L-A 
virions were incubated only with GTP and ATP, a 
short transcript (6 nt) was produced (Fig. 1B, lane 
2). A further inclusion of UTP in the reaction 
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increased the length to 16 nt (Fig. 1B, lane 3). 
These short transcripts were apparently released 
from the RNA polymerase complex because of the 
lack of incoming nucleotides for elongation. The 
addition of CTP at 30 min did not convert the 16 nt 
species into full-size transcript (Fig. 1B, lane 9), 
and we did not observe these short transcripts 
when virions were incubated with four NTPs (Fig. 
1B, lane 10).  The 16 nt transcript has a single G at 
the 5’ end, therefore only the 5’ terminal 
nucleotide in the molecule can be labeled with [α-
32P]GTP. This transcript was purified from an 
acrylamide gel and treated with 5’ exonuclease. As 
shown in Fig. 1C this species was resistant to the 
5’ exonuclease but became sensitive to it after 
treatment with RNA 5’ polyphosphatase, a 
characteristic similar to the one observed with the 
full-size transcript. Then the 16 nt transcript 
labeled with [α-32P]GTP was digested with S1 
nuclease and analyzed on PEI cellulose. S1 
degrades single-stranded RNA endonucleolytically 
to yield 5’-phosphoryl-terminated products. As 
shown in Fig. 1D (left panel), the labeled 5’ 
terminal nucleotide comigrated with GDP, 
indicating that the L-A transcript has a diphosphate 
at the 5’ end. 
 
GDP is not Essential for Transcription 
Initiation- Incubation of L-A virions with ATP and 
[α-32P]UTP did not produce transcripts (Fig. 2A, 
lane 3), indicating that the guanine nucleotide is 
essential for initiation of transcription. dGTP also 
failed to initiate transcription (Fig. 2A, lane 8). 
Among the guanine nucleotides examined, GDP 
was the best substrate for the initiation reaction, 
consistent with the results that the 5’ end of the 
transcript is diphosphorylated.  GMP was also 
incorporated well into the 16 nt transcript (Fig. 2A, 
lane 4). A cap analogue  (m7GpppG) could initiate 
transcription whose product run as a 17mer 
because of the extra m7G at the 5’ end (Fig. 2A, 
lane 7). This 17mer, unlike GTP- or GDP-primed 
transcript, was resistant to the 5’ exonuclease even 
after treatment with RNA 5’ polyphosphatase (Fig. 
2B, lane 6). The 17mer was converted to 5’ 
monophosphorylated 16mer by the tobacco acid 
pyrophosphatase (Fig. 2B, lane 7), and the 
resulting product was now sensitive to the 5’ 
exonuclease (Fig. 2B, lane 8). These results clearly 
demonstrate that a cap analogue (m7GpppG) can 
be incorporated into the 5’ end of the transcript, 
and that GDP is not essential for transcription 
initiation.   GTP and GDP analogues (γ-S-GTP and 
β-S-GDP) could initiate transcription and the 
amounts of 16 nt transcripts were comparable to 
those produced by the respective bona fide 
nucleotides (Fig. 2C). Because γ-S-GTP is non-
hydrolysable, the results again confirm that GDP is 
not essential for initiation. It also indicates that 
transcription initiation and conversion of the 5’ 
triphosphate of the transcript (or GTP) to 5’ 
diphosphate are two distinct reactions. 
 
GMP-Primed Transcript Has Diphosphate 
at the 5’ End- GMP can initiate transcription as 
efficiently as GDP. The 16 nt product was resistant 
to Terminator 5’ exonuclease (Fig. 2A, lane 1), 
indicating that its 5’ end is no longer 
monophosphorylated. We speculated that the 5’ 
end of the molecule was modified to diphosphate. 
To prove this, we carried out the transcription 
reaction in the presence of [γ-32P]ATP. As shown 
in Fig. 3A, the 16 nt transcript incorporated 
radioactivity only when transcription was primed 
with GMP. The labeled transcript was then isolated 
from the gel and digested with S1 nuclease. The 
radioactivity comigrated with GDP in PEI 
cellulose (Fig. 3B, lane 2), indicating that the 
GMP-primed transcript has diphosphate at the 5’ 
end. Furthermore, the transcript released labeled 
inorganic phosphate when treated with bacterial 
alkaline phosphatase (Fig. 3B, lane 4) or RNA 5’ 
polyphosphatase (Fig. 3B, lane 3). Because the 
latter enzyme cannot act on 5’ 
monophosphorylated RNA, this result clearly 
demonstrated that the labeled phosphate derived 
from [γ-32P]ATP was present in the β-position of 
the 5’ diphosphate in the transcript. Furthermore, 
since the GDP-primed transcript was not labeled, 
this result indicates that the labeled β phosphate 
was acquired by a kinase reaction but not by a 
simple exchange reaction.  
 
Nucleoside Triphosphatase Activity 
Associated with L-A Virions- The 5’ triphosphate 
of GTP was converted to diphosphate when the 
nucleotide was incorporated into the 5’ end of L-A 
transcript. It suggests that the L-A virion has RNA 
or nucleoside triphosphatase activity. It is known 
that the yeast CTL1 gene product possesses RNA 
triphosphatase activity (35). It localizes in the 
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cytoplasm but its physiological role is unknown. A 
ctl1Δ strain is viable and can harbor L-A virus. L-
A virions isolated from this mutant had 
transcriptase activity and synthesized the 16 nt 
transcript in the absence of CTP (not shown). The 
16 nt transcript labeled with [α-32P]GTP was gel-
purified and treated with S1 nuclease. As shown in 
Fig. 1D (right panel), the 5’ terminal nucleotide 
released by S1 digestion was GDP, indicating that 
the transcript had a diphosphate at its 5’ terminus. 
Therefore, CTL1 is not responsible for the 
conversion of triphosphate to diphosphate.  
We found a weak nucleoside 
triphosphatase activity associated with L-A virions 
in a CsCl gradient (Fig. 4D). A gradient from an L-
A-negative strain had no such activity (Fig. 4C).  
The L-A peak fraction (Fr. 5) released a low 
amount of Pi from ATP or GTP alone, but its 
activity was greatly stimulated when both 
nucleotides were present together (Supplemental 
Fig. 1SA). GTP can be replaced by GDP, γ-S-GTP, 
or β-S-GDP for stimulation, all of which can prime 
the transcription reaction, while a non-priming 
nucleotide CTP failed to stimulate Pi release 
(Supplemental Fig. 1SA and B). A potent 
inorganic pyrophosphatase activity has been 
observed to be associated with L-A virions (36). It 
is likely that the enhanced release of Pi was not 
caused by nucleoside triphosphatase activity per se 
but by hydrolysis of inorganic pyrophosphate 
generated as a byproduct from polymerization of 
the 6 nt transcript (5’ GAAAAA). Therefore, we 
carried out the reaction using [α-32P]GTP and 
directly analyzed the products with PEI cellulose. 
As shown in Fig. 4E, lane 2, the L-A peak fraction 
(Fr. 5) produced GDP, confirming its 
triphosphatase activity. In the presence of ATP, the 
label in GDP decreased and a new radioactive spot 
migrating between GDP and GTP appeared (Fig. 
4E, lane 4). We confirmed that the latter spot 
comigrated with the gel-purified 6 nt 5’ GAAAAA 
transcript. Because this transcript has a single G in 
the molecule, the results raise the possibility that 
GDP produced by the nucleoside triphosphatase 
activity was incorporated into its 5’ end, resulting 
in the concomitant loss of radioactivity in GDP. 
When a similar reaction was carried out by 
substituting ATP with CTP, however, the label in 
GDP again decreased by the addition of CTP (Fig. 
4F, lane 4). Because CTP cannot support 
polymerization of even short transcripts without 
ATP and UTP, the results suggest that the decrease 
of GDP was not caused by its incorporation into 
RNA transcripts but by the competitive inhibition 
of the triphosphatase activity by ATP or CTP. It is 
also possible that unincorporated GDP was 
reconverted to GTP by virion-associated 
nucleoside diphosphate kinase (36). 
  
M1 Transcript has Diphosphate at the 5’ 
End- M1, a satellite RNA of L-A virus, utilizes L-
A encoded proteins to encapsidate and replicate its 
RNA genome. M1 can replicate and be maintained 
in the cell without L-A virus if the viral proteins 
are provided from a vector. We isolated M1 virions 
from L-A virus-free cells to avoid the preparation 
from being contaminated with L-A virus. M1 
virions purified through a CsCl gradient 
synthesized full-length M1 transcripts in the 
presence of four NTPs and produced a short 17 nt 
transcript when CTP was omitted (Fig. 5B). The 
17 nt transcript labeled with [α-32P]GTP was 
purified through an acrylamide gel, treated with S1 
nuclease, and analyzed by PEI cellulose 
chromatography. As shown in Fig. 5C, lane 2, the 
transcript produced two spots corresponding to 
GDP and GMP and their ratio was 1:2.1. In 
addition to the 5’ terminal G, the 17 nt transcript 
has two additional Gs (Fig. 5A) and these internal 
Gs are expected to be released as GMP upon S1 
digestion. The results, therefore, suggest that GDP 
was derived from the 5’ end of the transcript and 
that the transcript thus has diphosphate at the 5’ 
end. To confirm that GDP was derived from the 5’ 
end, the 17 nt transcript was treated with RNA 5’ 
polyphosphatase, ethanol precipitated and then 
digested with S1 nuclease. As shown in Fig. 5C, 
lane 3, now, the transcript only produced GMP, 
indicating that GDP was really released from the 
5’ end. 
 
5’ Diphosphorylated L-A Transcript is 
Resistant to Ski1p 5’ Exonuclease- L-A transcript 
has a diphosphate at the 5’ end. We wondered 
whether the viral transcript is susceptible to Ski1p 
5’ exonuclease. A. Stevens purified this enzyme 
and performed an extensive biochemical analysis 
on it.  It is now well known that the nuclease 
digests 5’ monophosphorylated RNA as substrate 
but works poorly on 5’ triphosphorylated or 
capped RNA (37). However, we did not find 
information on its reactivity toward 5’ 
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diphosphorylated RNA. We, therefore, purified 
Ski1p as a TAP fusion protein from yeast cells by 
one-step purification using calmodulin-affinity 
resin following the method described in (31). Fig. 
6A shows the elution profile of Ski1p from the 
affinity resin visualized by silver staining. RNA 
substrates with different 5’ termini but having the 
same nucleotide sequence were made in vitro using 
T7 RNA polymerase and served to test the 
specificity of the purified enzyme. As shown in 
Fig. 6B the protein efficiently digested 5’ 
monophosphorylated RNA (lane 4) but hardly 
worked on 5’ triphosphorylated (lane 2) or capped 
RNA (lane 6), confirming the specificity ascribed 
to the enzyme. We made the 16 nt L-A transcript 
in vitro by incubating L-A virions in a CTP-
omitted transcription reaction and treated it with 
purified Ski1p. As shown in Fig. 6C, the transcript 
was largely resistant to Ski1p (lane 2) but became 
completely digested with the enzyme after 
pretreatment with RNA 5’ polyphosphatase (lane 
4), the same digestion pattern observed with the 
commercially available Terminator 5’ exonuclease 
(Fig. 1C). From these results we concluded that L-
A viral transcript made in vitro is a poor substrate 
for the Ski1p 5’ exonuclease. 
   
DISCUSSION 
 
In this work we have demonstrated that L-
A transcripts made in vitro by L-A virions are 5’ 
diphosphorylated. More significantly, irrespective 
of whether transcription was primed by GTP or 
GMP, the guanine nucleotide incorporated at the 5’ 
terminus was diphosphorylated. Thus the virus 
deliberately synthesizes RNA transcript with 5’ 
diphosphate. M1, a satellite RNA of L-A virus, 
utilizes Gag and Gag-Pol of the helper virus to 
encapsidate and replicate its RNA genome. 
Isolated M1 virions likewise synthesized 
transcripts with 5’ diphosphate.  We have also 
demonstrated that the L-A transcript made in vitro 
is a poor substrate for the Ski1p 5’ exonuclease. 
When the 5’ end of the transcript was converted 
from diphosphate to monophosphate, however, 
Ski1p efficiently digested it. Previously we 
observed that the deletion of SKI1 resulted in a 5- 
to 10-fold increase in the copy number of L-A 
virus and that overexpression of Ski1p cured L-A 
virus from the cell at a high frequency (22). 
Because Ski1p is the major exonuclease involved 
in mRNA degradation in the budding yeast (19), 
our results suggest that the virus makes its 
transcript 5’ diphosphorylated apparently to protect 
it from a direct attack of the potent Ski1p. Our 
results also suggest that the host cell possesses an 
RNA diphosphatase activity in the cytoplasm to 
convert the viral transcript from diphosphate to 
monophosphate at the 5’ end. Consistent with this 
view is that in ski1Δ strains L-A transcripts 
accumulate in large amounts and can easily be 
detected by Northern hybridization. Furthermore 
these transcripts are 5’ monophosphorylated, as 
judged from their susceptibility to Terminator 5’ 
exonuclease or purified Ski1p2. In wild type strains 
these transcripts are quickly digested by Ski1p and 
do not accumulate in large quantities. These 
observations suggest that in a hypothetical RNA 
diphosphatase-negative strain viral transcripts will 
be stabilized because of the inability of Ski1p to 
directly attack them. Thus these mutants are 
expected to exhibit a “superkiller” phenotype when 
harboring the satellite M1 dsRNA.  
Another possible role for the 5’ 
diphosphate status of the viral transcript is on 
translation and is more speculative. Here we 
demonstrated that the cap analogue m7GpppG can 
be used to prime transcription in vitro by L-A 
virions. Barbone et al. (38) reported that viral 
transcripts made in vitro in the presence of the cap 
analogue are translated in a yeast cell-free 
translation system 8- to 15-fold more efficiently 
than the ones made in its absence, although they 
failed to directly prove its incorporation into viral 
transcripts. These data together suggest that viral 
transcripts with 5’ diphosphate are poor templates 
for translation but that the incorporation of the cap 
structure at the 5’ end converted them to more 
efficient templates. In the mRNA capping reaction, 
the RNA guanylyltransferase (GTase) transfers 
GMP to the diphosphate end of pre-mRNA 
through a covalent enzyme-GMP intermediate. It 
has been known that L-A Gag protein binds to 5’ 
capped mRNAs and forms a covalent bond with 
m7GMP through His-154 while releasing the 
mRNA body (25, 39). This raises the possibility 
that the m7GMP attached to His-154 can be 
transferred to the diphosphate end of an emerging 
viral transcript, thus forming a 5’ cap structure on 
the RNA. A 5’ capped species of viral RNA has 
not been detected yet (40) presumably because the 
efficiency of transfer is low. This cap-snatching 
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hypothesis was originally described in (25). In the 
conventional capping reaction, the GTase forms a 
covalent bond with GMP through Lys but not His. 
However, it has recently been demonstrated that in 
the capping reaction of vesicular stomatitis virus 
(VSV), L protein forms an intermediate by 
covalently binding the 5’ monophosphorylated pre-
mRNA through His and transfers the bound pre-
mRNA to GDP (41).   It appears that members of 
the Alphavirus-like superfamily also utilize His to 
form a phosphoamide bond with m7GMP and 
transfer the m7GMP moiety to the 5’ diphosphate 
end of a viral transcript during the capping reaction 
(42 - 44). L-A Gag with mutations at His-154 
failed to form a covalent bond with m7GMP but 
did not affect replication and maintenance of M1 
(25). Therefore, those reactions, including 
transcription ((+) strand RNA synthesis), 
encapsidation of (+) strand into the virion and (-) 
strand synthesis inside the virion, are not affected 
by the mutations. Furthermore, M1 virions with a 
mutant Gag (Arg-154) synthesize M1 transcripts 
with 5’ diphosphate as wild type virions do2. 
Interestingly, however, the expression of M1-
encoded killer toxin is severely compromised in 
vivo by the mutations at His-154 (25), suggesting a 
specific role of His-154 on translation. Therefore, 
these data fit well within the framework of this 
capping hypothesis. 
We observed a weak nucleoside 
triphosphatase activity associated with L-A 
virions. However, it is not clear whether this 
activity is involved in the synthesis of the 5’ 
diphosphorylated transcript primed with GTP. 
RNA polymerase may preferentially incorporate 
GDP generated by nucleoside triphosphatase over 
GTP to prime transcription. The polymerase itself 
may be able to convert GTP to GDP during 
transcription initiation. Finally, the conversion may 
occur post-transcriptionally on the nascent 
transcript during its release from the virion through 
a pore in the capsid. Our data indicate that the host 
CTL1 RNA triphosphatase is not involved in this 
process. The conversion from triphosphate to 
diphosphate, however, is not essential for the 
initiation of transcription because a cap analogue  
(m7GpppG) or γ-S-GTP could prime transcription 
efficiently. GDP was a better substrate to prime 
transcription than GTP. This raises the possibility 
that the conversion of GTP to GDP is slow and this 
slow process might be responsible for the low 
efficiency of the GTP-primed reaction. However, 
because γ-S-GTP could prime transcription as 
efficiently as GTP, this possibility is unlikely. We 
demonstrated that GMP-primed transcript had also 
diphosphate at the 5’ end, the β-phosphate of 
which was derived from the γ-phosphate of ATP. 
This kinase reaction could occur before, during or 
after transcription initiation, as discussed above for 
the conversion from triphosphate to diphosphate. It 
is noteworthy to mention that, when M1 
transcription was primed by GMP in the presence 
of ATP and UTP, we observed not the 10 nt 
transcript but a longer 17 nt species that had 
incorporated two internal Gs before termination 
due to the lack of CTP2. This suggests that the 
virion sequentially converted GMP to GDP and 
then to GTP at the expense of ATP, and used this 
newly made GTP to synthesize the 17 nt species. It 
is thus conceivable that the GDP produced in this 
process was incorporated at the 5’ end of the viral 
RNA during transcription initiation. Leibowitz’s 
lab (36) has observed that L-A virions are 
associated with numerous nucleotide-metabolizing 
enzyme activities, including nucleoside 
triphosphate phosphotransferase, nucleoside 
diphosphate and monophosphate kinases, in 
addition to inorganic pyrophosphatase activity, and 
speculated that these enzymes may allow the virus 
to utilize nucleotide pools distinct from those used 
in host cell transcription. However, the results 
shown in this work raise the possibility that some 
of the enzymatic activities associated with the 
virion are directly involved in the metabolism of 
phosphate group at the 5’ termini of viral 
transcripts. L-A virus encodes only two proteins, 
Gag and Gag-Pol. Gag has decapping activity of 
mRNA and the Pol domain of the fusion protein 
has RNA-dependent RNA polymerase motifs and 
is also involved in packaging of viral RNA into 
virions (45). It is an open question whether the 
viral proteins further possess these phosphate-
metabolizing enzymatic activities. Alternatively, 
the virus may recruit host enzymes and specifically 
incorporate them into the virion to process the 5’ 
ends during transcription. 
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LEGENDS TO FIGURES 
Figure 1. GTP-primed L-A transcript has diphosphate at the 5’ end. A. 32P-labeled, full-sized 
L-A transcripts made in vitro by L-A virions were treated with Terminator 5’ exonuclease (Ter Ex) and/or  
RNA 5’ polyphosphatase (RPPase) as indicated below the panel and separated in an agarose gel. L-A 
ssRNA was visualized by ethidium bromide staining (upper panel) or by autoradiography (lower panel). 
λ, λ HindIII fragments as size markers. B. Upper panel shows the 5’ terminal region of L-A ssRNA 
transcript. The first U and C appear at positions 7 and 17, respectively (indicated by the arrows). The 
asterisk (*) indicates the position that can be labeled with [α-32P]GTP in an in  vitro transcription reaction. 
Lower panel shows transcription products made in vitro by L-A virions. Transcripts were labeled with [α-
32P]GTP, separated in a 15% acrylamide gel and visualized by autoradiography. Lanes 1 to 3, L-A virions 
were incubated for 30 min in a transcription reaction from which ATP, UTP and CTP (lane 1), or UTP 
and CTP (lane 2), or CTP (lane 3) was omitted. Lanes 4 to 8, L-A virions were incubated for the times 
indicated below the panel in CTP-omitted transcription reaction. Lane 9, L-A virions were incubated in a 
CTP-omitted transcription reaction. After 30 min incubation excess amounts (1 mM each) of non-labeled 
GTP and CTP were added to the mixture and the reaction was carried out 30 min further. Lane 10, same 
as in lane 9, except that the non-labeled GTP and CTP were added at 0 min. The reaction was carried out 
for 60 min. The mobility of full-sized, 16 nt, and 6 nt transcripts as well as un-incorporated GTP is 
indicated. The 16 nt transcripts comigrated with bromophenol blue (BPB) in this gel system. C. [α-
32P]GTP-primed 16 nt transcripts made by L-A virions in a CTP–omitted reaction were treated with RNA 
5’ polyphosphatase and/or Terminator 5’ exonuclease as indicated below the panel and separated in a 15% 
acryalamide gel. An autoradiogram of the gel is shown. D. [α-32P]GTP-primed 16 nt transcripts made by 
L-A virions isolated from CTL1 (left panel, WT) or ctl1Δ (right panel, ctl1Δ) strain were purified in a 15% 
acrylamide gel. The transcripts were treated with or without S1 nuclease and analyzed on PEI cellulose 
with 1 M LiCl. The positions of non-labeled GTP, GDP and GMP are indicated by the dotted ovals.  
Figure 2. Nucleotide specifity of transcription priming- A to C. Short transcripts (16 or 17 nt) 
were made by L-A virions in a CTP-omitted transcription reaction. The transcripts were labeled with [α-
32P]UTP and primed without (None) or with 20 µM guanine nucleotides or their analogues as indicated 
above the panels. The products were separated in a 15% acrylamide gel and visualized by 
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autoradiography. Some of the products were pretreated, before electrophoresis, with RNA 5’ 
polyphosphatase (RPPase), tobacco acid pyrophosphatase (PyroPase), or Terminator 5’ exonuclease (Ter 
Ex) as indicated below the panels. It should be noticed that the cap analogue (m7GpppG)-primed 
transcripts migrate as 17-mer because of an extra G at the 5’ end (panel A, lane 7). Its size can be reduced 
to 16-mer by tobacco acid pyrophosphatase treatment (Panel B, lane 7). D. The nucleotide sequence of L-
A positive strand at the 5’ end region. The asterisks indicate the positions in the transcripts, which can be 
labeled with  [α-32P]UTP in vitro.  
Figure 3. GMP-primed transcript has diphosphate at the 5’ end, and its β  phosphate is 
derived from ATP. A. Only GMP-primed transcript can be labeled with [γ-32P]ATP in in vitro 
transcription. L-A virions were incubated with UTP and [γ-32P]ATP in the presence of 20 µM GMP (lane 
2), GDP (lane 3), or GTP (lane 4) or in the absence of guanine nucleotides (lane 1) as control. The 16 nt 
transcript was separated in a 15% acrylamide gel and visualized by autoradiography. B. GMP-primed 16 
nt transcripts described above were isolated from the gel and treated with S1 nuclease (lane 2, S1), RNA 
5’ polyphosphatase (lane 3, RPPase), or bacterial alkaline phosphatase (lane 4, BAP) and analyzed on PEI 
cellulose with 1 M LiCl. Lane 1, No enzyme treated 16 nt transcripts. Lane 5, [γ-32P]ATP. An 
autoradiogram of the thin layer is shown. The positions of non-labeled GTP, GDP and GMP are shown by 
the dotted ovals. C. The 5’ end region of L-A transcript. The asterisk indicates that the β phosphate at the 
5’ terminus is derived from the γ phosphate of ATP when transcription is primed with GMP.   
Figure 4. Association of a weak nucleoside triphosphatase activity with L-A virions. A and B. 
L-A virions were isolated and purified through CsCl gradient centrifugation. Fr. 5 contained the main peak 
of L-A virions. Fr. 1 and F. 13 are the bottom and top of the gradient. In A, L-A dsRNA was extracted 
from the gradient, separated in an agarose gel and visualized with ethidium bromide staining. In B, protein 
in the gradient was separated in a SDS-polyacrylamide gel and visualized by Coomassie-brilliant-blue 
staining. Gag and Gag-Pol proteins are indicated. D. CsCl gradient fractions shown in A and B were 
incubated with [γ-32P]GTP and inorganic phosphate (Pi) released was separated in PEI cellulose with 1 M 
LiCl. An autoradiogram is shown. The leftist lane (-) contains no gradient fraction and serves as control. 
C. Same as D except that the gradient was made of an extract from an L-A-o strain. Only the upper part of 
the thin layer is shown. E. [α-32P]GTP was incubated with or without the L-A main peak fraction (Fr. 5) 
(L-A virion). ATP was also added as indicated below the panel. The products were separated on PEI 
cellulose and visualized by autoradiography. The positions of GTP, GDP, GMP, inorganic phosphate (Pi), 
and a 6 nt transcript (GAAAAA) are indicated. F. Same as E except that ATP was substituted with CTP.  
Figure 5. M1 transcript also has diphosphate at the 5’ end. A. The 5’ end region of M1 
transcript. The first C appears at position 18. M1 virions makes a 17 nt transcript in a CTP-omitted 
transcription reaction as shown in B. In this gel system (15% acryalmide) the 17 nt transcript comigrates 
with bromophenol blue (BPB). The asterisks in A indicate three positions in the 17 nt transcript, which can 
be labeled with [α-32P]GTP. Upon S1 nuclease digestion the two internal Gs in the transcript will be 
released as GMP, while the 5’ terminal G would be GDP if the transcript has diphosphate at the 5’ end. C. 
[α-32P]GTP-labeled M1 17 nt transcript was isolated from an acrylamide gel and treated with S1 nuclease. 
The digest was analyzed on PEI cellulose with 1 M LiCl (lane 2). The ratio of radioactive label in GDP 
and GMP quantified by phosphoimager was 1:2.1. Lane 1 indicates non-S1 digested sample. In lane 3, the 
17 nt transcript was first treated with RNA 5’ polyphosphatase to eliminate the β phosphate at the 5’ end. 
After ethanol precipitation, then, the transcript was digested with S1 nuclease. 
Figure 6. L-A transcript made in vitro is resistant to Ski1p. A. Purification of Ski1p. Ski1p-
TAP was purified through a calmodulin affinity resin column. The bound protein was eluted stepwise with 
a buffer containing EGTA. Protein was separated with SDS-PAGE and visualized by silver staining. Lane 
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1, the last wash of the column. Lanes 2 to 7, fractions eluted with EGTA. M, molecular standards (kDa). 
B. Specificity of purified Ski1p. Transcripts bearing 5’ pppG-, 5’ pG- or 5’ cap-structure were made in 
vitro by T7 RNA polymerase using the same DNA template as described in Experimental Procedures. 
The transcripts were incubated with Ski1p and the digest was separated in an agarose gel and visualized 
by ethidium bromide staining. C. 32P-labeled 16 nt transcript was made in vitro by L-A virions in a CTP-
omitted transcription reaction and treated with RNA 5’ polyphosphatase (RPPase) and/or purified Ski1p 
as indicated below the panel. Then the transcript was separated in a acrylamide gel and visualized by 
autoradiography.  
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FIGURE 4 
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FIGURE 5 
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FIGURE 6 
 
 
 
